Xencor, Inc Weighted Average Number of Shares Outstanding, Basic and Diluted
Xencor, Inc (XNCR) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 58.00 million shares for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-05.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2021-05-05
- Xencor, Inc weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 58.00M shares, a 1.84% increase year-over-year.
- Xencor, Inc weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-03-31 was 56.95M shares.
- Xencor, Inc weighted average number of shares outstanding, basic and diluted for the quarter ending 2018-06-30 was 55.68M shares, a 19.05% increase year-over-year.
- Xencor, Inc weighted average number of shares outstanding, basic and diluted for the quarter ending 2018-03-31 was 47.75M shares, a 2.48% increase year-over-year.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month |
|---|---|---|---|
| 2021-03-31 | 58.00M shares 10-Q · filed 2021-05-05 | ||
| 2020-03-31 | 56.95M shares 10-Q · filed 2021-05-05 | ||
| 2018-06-30 | 55.68M shares 10-Q · filed 2018-08-07 | 51.74M shares 10-Q · filed 2018-08-07 | |
| 2018-03-31 | 47.75M shares 10-Q · filed 2018-05-07 | ||
| 2017-06-30 | 46.77M shares 10-Q · filed 2018-08-07 | 46.68M shares 10-Q · filed 2018-08-07 | |
| 2017-03-31 | 46.60M shares 10-Q · filed 2018-05-07 | ||
| 2016-03-31 | 40.63M shares 10-Q · filed 2017-05-10 | ||
| 2015-09-30 | 40.47M shares 10-Q · filed 2015-11-04 | 40.43M shares derived: average of 2 quarters · filed 2015-11-04 | 38.51M shares 10-Q · filed 2015-11-04 |
| 2015-06-30 | 40.39M shares 10-Q · filed 2015-08-05 | 37.52M shares 10-Q · filed 2015-08-05 | |
| 2015-03-31 | 34.30M shares 10-Q · filed 2016-05-02 | ||
| 2014-09-30 | 31.40M shares 10-Q · filed 2015-11-04 | 31.38M shares derived: average of 2 quarters · filed 2015-11-04 | 31.38M shares 10-Q · filed 2015-11-04 |
| 2014-06-30 | 31.37M shares 10-Q · filed 2015-08-05 | 31.37M shares 10-Q · filed 2015-08-05 | |
| 2014-03-31 | 31.36M shares 10-Q · filed 2015-05-05 | ||
| 2013-03-31 | 72.30K shares 10-Q · filed 2014-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |